ArticlePDF Available

Procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa–

Authors:

Abstract and Figures

Epidemiologic studies have linked flavonoid-rich foods with a reduced risk of cardiovascular mortality. Some cocoas are flavonoid-rich and contain the monomeric flavanols (-)-epicatechin and (+)-catechin and oligomeric procyanidins formed from these monomeric units. Both the monomers and the oligomers have shown potential in favorably influencing cardiovascular health in in vitro and preliminary clinical studies. Although previous investigations have shown increasing concentrations of (-)-epicatechin in human plasma after cocoa consumption, no information is available in the published literature regarding the presence of procyanidins in human plasma. This study sought to determine whether procyanidins can be detected and quantified in human plasma after acute consumption of a flavanol-rich cocoa. Peripheral blood was obtained from 5 healthy adult subjects before (baseline, 0 h) and 0.5, 2, and 6 h after consumption of 0.375 g cocoa/kg body wt as a beverage. Plasma samples were analyzed for monomers and procyanidins with the use of reversed-phase HPLC with coulometric electrochemical array detection and liquid chromatography-tandem mass spectrometry. Procyanidin dimer, (-)-epicatechin, and (+)-catechin were detected in the plasma of human subjects as early as 0.5 h (16 +/- 5 nmol/L, 2.61 +/- 0.46 micro mol/L, and 0.13 +/- 0.03 micro mol/L, respectively) after acute cocoa consumption and reached maximal concentrations by 2 h (41 +/- 4 nmol/L, 5.92 +/- 0.60 micro mol/L, and 0.16 +/- 0.03 micro mol/L, respectively). Dimeric procyanidins can be detected in human plasma as early as 30 min after the consumption of a flavanol-rich food such as cocoa.
Content may be subject to copyright.
798 Am J Clin Nutr 2002;76:798–804. Printed in USA. © 2002 American Society for Clinical Nutrition
Procyanidin dimer B2 [epicatechin-(4-8)-epicatechin] in human
plasma after the consumption of a flavanol-rich cocoa
1–3
Roberta R Holt, Sheryl A Lazarus, M Cameron Sullards, Qin Yan Zhu, Derek D Schramm, John F Hammerstone,
Cesar G Fraga, Harold H Schmitz, and Carl L Keen
ABSTRACT
Background: Epidemiologic studies have linked flavonoid-rich
foods with a reduced risk of cardiovascular mortality. Some
cocoas are flavonoid-rich and contain the monomeric flavanols
()-epicatechin and (+)-catechin and oligomeric procyanidins
formed from these monomeric units. Both the monomers and the
oligomers have shown potential in favorably influencing cardio-
vascular health in in vitro and preliminary clinical studies.
Although previous investigations have shown increasing concen-
trations of ()-epicatechin in human plasma after cocoa con-
sumption, no information is available in the published literature
regarding the presence of procyanidins in human plasma.
Objective: This study sought to determine whether procyanidins
can be detected and quantified in human plasma after acute con-
sumption of a flavanol-rich cocoa.
Design: Peripheral blood was obtained from 5 healthy adult sub-
jects before (baseline, 0 h) and 0.5, 2, and 6 h after consumption
of 0.375 g cocoa/kg body wt as a beverage. Plasma samples were
analyzed for monomers and procyanidins with the use of reversed-
phase HPLC with coulometric electrochemical array detection and
liquid chromatography–tandem mass spectrometry.
Results: Procyanidin dimer, ()-epicatechin, and (+)-catechin
were detected in the plasma of human subjects as early as 0.5 h
(16 ± 5 nmol/L, 2.61 ± 0.46 mol/L, and 0.13 ± 0.03 mol/L,
respectively) after acute cocoa consumption and reached maximal
concentrations by 2 h (41 ± 4 nmol/L, 5.92 ± 0.60 mol/L, and
0.16 ± 0.03 mol/L, respectively).
Conclusion: Dimeric procyanidins can be detected in human
plasma as early as 30 min after the consumption of a flavanol-rich
food such as cocoa. Am J Clin Nutr 2002;76:798–804.
KEY WORDS Cocoa, chocolate, catechin, epicatechin,
procyanidin, flavonoid, reversed-phase HPLC, coulometric
electrochemical array detection
INTRODUCTION
A diet rich in fruit, nuts, and vegetables has been associated
with a reduced risk of cardiovascular disease (1, 2). In addition to
vitamins C, E, and the carotenoids, fruit, nuts, and vegetables con-
tain a complex array of phenolic compounds that may contribute
to increases in the plasma antioxidant capacity (3–5). Although
the extent to which an enhanced plasma antioxidant capacity may
contribute to improved health is a subject of debate, most investi-
gators view increases in oxidant defense as positive. Flavonoids
1
From the Departments of Nutrition (RRH, QYZ, DDS, and CLK) and
Internal Medicine (CLK), University of California, Davis; Analytic & Applied
Sciences, Mars Incorporated, Hackettstown, NJ (SAL, JFH, and HHS); the
Department of Biochemistry, Emory University, Atlanta (MCS); and Physical
Chemistry-PRALIB, School of Pharmacy and Biochemistry, University of
Buenos Aires (CGF).
2
Supported by grants from the National Institutes of Health (DK-35747)
and Mars Incorporated.
3
Address reprint requests to CL Keen, Department of Nutrition, University
of California, Davis, One Shields Avenue, Davis, CA 95616-8669. E-mail:
clkeen@ucdavis.edu.
Received April 13, 2001.
Accepted for publication October 18, 2001.
represent one class of phenolic compounds that has attracted con-
siderable attention. Epidemiologic studies suggest that the con-
sumption of a flavonoid-rich diet reduces an individual’s risk of
cardiovascular morbidity and mortality (6–8). Cocoa can be a rich
source of flavonoids and was historically used as a medicine to
combat inflammation, pain, and numerous other ailments (9). Like
wine and tea, cocoa flavanols consist of a complex mixture of the
monomeric (+)-catechin (catechin) and ()-epicatechin (epicate-
chin) and the oligomers of these monomeric base units known as
procyanidins (10).
In in vitro systems, extracts of cocoa flavanols and their
oligomers have the ability to inhibit LDL oxidation (11), prevent
peroxynitrite-dependent oxidation and nitration (12, 13), promote
endothelium-dependent relaxation (14), and modulate the pro-
duction of inflammatory cytokines (15, 16). The in vitro effects
observed with the monomers are often significantly different from
those observed with the oligomers, suggesting that there may be
considerable structure specificity for these compounds. Although
the potent in vitro effects of the flavanols and their oligomers have
generated considerable interest in these compounds, it has been
suggested that their in vivo effects may be minimal because of
gastric degradation (17). Thus, it is important to determine
whether the oligomers can be absorbed from the diet.
In a recent study (18) we used a sensitive and selective method
to measure plasma epicatechin concentrations after acute cocoa
consumption. In the current study we modified this method to
enable us to simultaneously measure epicatechin, catechin and
the procyanidin dimer B2 [epicatechin-(4-8)-epicatechin] in
human plasma after the acute consumption of a flavanol-rich
cocoa. Furthermore, the chemical identity of these compounds
by guest on June 6, 2013ajcn.nutrition.orgDownloaded from
EPICATECHIN, CATECHIN, AND DIMERS IN PLASMA 799
was assessed by liquid chromatography–tandem mass spectrom-
etry (LC-MS/MS).
SUBJECTS AND METHODS
Subjects and clinical study design
Five nonsmoking adult volunteers (3 men and 2 women aged
23–34 y with an average body weight of 70.5 ± 4.6 kg) with no
apparent disease participated in the study. The health status of all
participants was evaluated via questionnaire, and written,
informed consent was given before participation in the study. The
study protocol was conducted, and approved, according to guide-
lines set by the Human Subjects Review Committee of the Uni-
versity of California, Davis.
Subjects were asked to abstain from alcohol, analgesics, and
flavonoid-rich foods (eg, fruit, vegetables, nuts, coffee, tea, juice,
and chocolate) on the day before the experiment. Baseline sam-
ples were drawn after a 12-h evening fast. The subjects then con-
sumed 0.375 g cocoa (Cocoapro; Mars Inc, Hackettstown, NJ)/kg
body wt in 300 mL water. One gram of the cocoa provided
12.2 mg monomers, 9.7 mg dimers, and 28.2 mg procyanidins
(trimers through decamers) (3). On average, the subjects ingested
a total dose of 26.4 g cocoa, providing 323 mg monomers and
256 mg dimers. In addition to the cocoa beverage, the subjects
were allowed to consume white bread.
Blood samples were drawn via venipuncture at baseline (0 h)
and 0.5, 2, and 6 h after cocoa consumption. Blood was collected
into two 10-mL Vacutainer tubes (Becton Dickinson, Franklin
Lakes, NJ) containing sodium heparin as an anticoagulant. Blood
was centrifuged at 1500 g at 4 C for 10 min, and the plasma
was separated and frozen at 80 C until analyzed.
Determination of plasma catechin, epicatechin, and
procyanidin dimers
Chemicals were purchased from Sigma Chemical Co (St Louis)
unless otherwise stated. Plasma samples were extracted as
described by Richelle et al (19) and Rein et al (18). The resulting
solution was filtered with a 0.22-m Ultrafree-MC low-binding
Durapore centrifugal filter (Millipore, Bedford, MA) and cen-
trifuged (10 000 g, 5 min, 4 C); 50 L of the filtered solution
was analyzed for catechin, epicatechin, and procyanidin dimers by
reversed-phase HPLC with coulometric multiple-array detection.
Chromatography was carried out by using an HP 1100 HPLC
system with Chemstation software, equipped with a quaternary
pump, temperature-controlled autosampler, column oven, and
diode array detector (Hewlett-Packard, Wilmington, DE) in series
with a CoulArray 5600 detector (ESA, Chelmsford, MA). Separa-
tion was achieved by using a reversed-phase Alltima C
18
column
(5 m, 150 mm 4.6 mm; Alltech Associates, Deerfield, IL) with
a C
18
5-m guard column (Alltech Associates) . The mobile phase
was mixed with 2 solvents: solvent A [40% methanol, 60%
100 mmol sodium acetate/L in water (EM Sciences, Darmstadt,
Germany), pH 5.0] and solvent B (7% methanol, 93% 100 mmol
sodium acetate/L in water, pH 5.0). A gradient elution was used at
a flow rate of 1 mL/min with the initial concentration of solvent A
set at 20%, which was held until 2 min. This was followed by a lin-
ear increase to 40% solvent A by 10 min, immediately followed
with another linear increase to 85% solvent A by 13 min. The sys-
tem was held at 85% of solvent A until 17 min, at which time a lin-
ear increase to 100% solvent A was achieved by 20 min. The system
was then linearly decreased to 40% solvent A by 23 min, followed
by another linear decrease to 20% solvent A by 25 min.
Coulometric electrochemical array detection was carried out by
using the following cell settings: 50, 65, 150, 200, 250, 300, 700,
and 800 mV. The resulting chromatographs were analyzed by using
CoulArray for WINDOWS software (ESA, Chelmsford, MA). Iden-
tification of epicatechin and catechin at 150 mV was based on
coelution with authentic standards and quantified by using external
standards. Identification of the procyanidin dimer peak at 700 mV
was based on coelution with authentic standards and quantified by
using external standards extracted from cocoa (Cocoapro) (3, 20).
Confirmation of procyanidin dimers with liquid
chromatography–tandem mass spectrometry
Experiments were performed on a Sciex API 3000 triple
quadropole mass spectrometer (Perkin-Elmer, Norwalk, CT) equipped
with a turbo ionspray source. All experiments were performed in the
negative ion mode. The ionspray needle was held at 4500 V while
the inlet voltage (orifice) was kept at 65 V to minimize collisional
decomposition of molecular ions before entry into the first quadropole.
Molecular ions of dimer were identified by simple MS analy-
sis of standard solutions. Product ion spectra of these species were
acquired by using Q1 to pass the molecular ion of interest. Nitro-
gen was used to collisionally activate precursor ion decomposi-
tion in the second quadropole, which was offset from the first
quadropole by 35 eV. Subsequently, formed product ions were
then detected by scanning the third quadropole.
Quantitative MS/MS data for procyanidin dimers was acquired by
multiple reaction monitoring experiments in which the first
quadropole was set to pass a specific precursor ion mass-to-charge
ratio (m/z) and the third quadropole was set to pass a structurally dis-
tinctive product ion m/z. The dimer transitions were 577.3/407.0,
577.3/289.0, and 577.3/125.0. Each transition was optimized with
regard to both ionization and collision energy to minimize collisional
decomposition of molecular ions before entry into the first quadropole
and maximize formation of structurally distinctive product ions. The
dwell time for multiple reaction monitoring transitions of each indi-
vidual molecular species was 30 ms when both monomer and dimer
were monitored and 60 ms when only the dimer was monitored.
Procyanidin dimer was confirmed in the plasma by using
reversed-phase LC-MS/MS. A 100-L aliquot of the plasma extract
in 0.25 mol perchloric acid/L in water was diluted to a final volume
of 200 L with water:methanol (90:10 by vol). A 50-L volume
was injected onto a 150 2.1 mm Discovery C
8
column (Supelco,
Bellefonte, PA) at a flow rate of 300 L/min. Solvent A was
water:methanol (90:10 by vol) and solvent B was 100% methanol.
The column eluent was directly infused into the ion source of the
mass spectrometer, which was operated at 500 C with a 6 L/min
nebulizing nitrogen gas flow. The elution protocol consisted of col-
umn preequilibration with 100% solvent A for 3 min followed by
sample injection, 7 min at 100% solvent A, a 1-min linear gradient
to 100% solvent B, and a 7-min wash with 100% solvent B.
Statistical analyses
Data were analyzed for differences by one-way analysis of
variance or Kruskal-Wallis one-way analysis of variance on
ranks (SIGMASTAT for WINDOWS, version 2.03; SPSS, Rich-
mond, CA). When appropriate, Tukey’s or Dunn’s all-pairwise-
comparison tests were used to identify differences between base-
line and results 0.5, 2, and 6 h after cocoa consumption.
Statistical significance was set at P < 0.05.
by guest on June 6, 2013ajcn.nutrition.orgDownloaded from
800 HOLT ET AL
FIGURE 1. Coulometric multiple-array chromatograms. A: 10 nmol (on-column) catechin standard [peak 1, 12.6 min; molecular weight (MW) = 289]
and 10 nmol epicatechin standard (peak 2, 16.9 min; MW = 289). B: 12.5 nmol procyanidin dimer B2 standard [epicatechin-(4-8)-epicatechin; peak 3,
14.7 min; MW = 578] and 12.5 nmol dimer B5 standard [epicatechin-(4-6)-epicatechin; peak 4, 20.3 min; MW = 578]. C: an extracted plasma sample
from one subject 2 h after cocoa consumption. The HPLC conditions are as described in the text.
RESULTS
Analytic determination of epicatechin, catechin, and
procyanidin dimers
The sensitivity and selectivity of coulometric electrochemical
array detection allowed us to measure not only epicatechin but
also catechin and the procyanidin dimers B2 and B5. A multiple-
array chromatograph for standards of catechin and epicatechin
[peaks 1 (12.6 min) and 2 (16.9 min), respectively] is depicted in
Figure 1A. Two procyanidin dimer peaks were found in the stan-
dard that was purified from cocoa; we previously characterized
these 2 peaks by nuclear magnetic resonance (21) as dimers B2
and B5 [peak 3 (14.7 min) and peak 4 (20.3 min), respectively;
Figure 1B]. Both epicatechin and catechin exhibit peak oxidation
responses at 150 mV followed by a second peak oxidation
response at 700 mV. The sample preparation and chromatography
did not fully resolve desired analytes from other coeluting plasma
components. However, the detection system selectively detected
catechin and epicatechin at the lower (150 mV) potential. A sim-
ilar strategy was used with the procyanidin dimers; however, to
achieve greater sensitivity, 700 mV was chosen as the analytic
potential. By choosing these 2 analytic potentials we were able to
measure plasma epicatechin and catechin and to simultaneously
detect low concentrations of dimer. A typical chromatograph at
150 and 700 mV for a 2-h plasma sample is depicted in Figure 1C.
The coulometric detection response was linear for on-column
standard curves with the use of the purified dimer B2 extract
between 290 and 29 ng. When plasma was spiked with purified
extracts of dimer, the recovery of B2 dimer was 103%. As previ-
ously reported, the recovery for catechin and epicatechin was
between 70% and 90% (18). The extraction procedure did not
yield additional dimer from plasma spiked with epicatechin and
catechin. The relative SDs for unspiked samples of 7 consecutive
analyses of dimer B2, catechin, and epicatechin were 12%, 7%,
and 4%, respectively. The limits of detection for dimer B2 and
dimer B5 on-column were 290 and 723 pg, respectively. These
detection limits allow for the measurement of plasma concentra-
tions of dimer B2 and B5 as low as 10 and 25 nmol/L, respectively.
Mass spectral identification of procyanidin dimers in plasma
To enhance the MS signal response, chromatography was not
used to resolve procyanidin dimers B2 and B5 in the purified stan-
dard. The molecular ions of the procyanidin dimers were identi-
fied by simple MS analysis of a standard solution (m/z: 577).
Because of background chemical noise or other intrinsic interfer-
ences that may generate ions having the same molecular ion (m/z),
by guest on June 6, 2013ajcn.nutrition.orgDownloaded from
EPICATECHIN, CATECHIN, AND DIMERS IN PLASMA 801
FIGURE 2. The structure of procyanidin dimer B2 [epicatechin-
(4-8)-epicatechin] with major fragmentations and the relative abundance
of product ion spectrum determined with tandem mass spectrometry. m/z,
mass-to-charge ratio; (M-H)
, molecular ion in negative mode.
FIGURE 3. Results of liquid chromatography–tandem mass spec-
trometry of the dimer standard, containing both dimer B2 and B5, spiked
into control plasma at 9.86 nmol/L (A) and dimers in an extracted plasma
sample (unspiked) from one subject 2 h after consumption of 0.375 g
cocoa/kg body wt (B). The data for both panels A and B represent the
mass–to–product ion pairs (577.3/407.0, 577.3/289.0, and 577.3/125.0)
produced from both dimer B2 and dimer B5. A plasma dimer B2 concen-
tration of 42.5 nmol/L was quantified in the sample represented in panel
B with the use of multiple-array coulometric detection.
we used MS/MS to further identify the ion (m/z: 577) as dimer.
MS/MS is used to fragment the ion of interest. Once fragmented,
the MS/MS product ion spectra of the dimer standard showed
3 structurally distinctive ion products of 125, 289, and 407 m/z
(Figure 2). It is important to note that when ionized, the 425-m/z
fragment represented in Figure 2 will lose a molecule of water,
producing the product ion of 407 m/z (Figure 2). The major prod-
uct ions that are produced from the dimer standard indicate that
fragmentation occurs at the linkage (m/z: 289) of the oligomer as
well as opening of the C rings (m/z: 125 and 407). The fragmen-
tation pattern of dimer B2 is represented in Figure 2. Although its
fragmentation pattern is not shown, the fragmentation dimer of B5
also involves simple opening of the C rings and linkage cleavage,
producing product ions similar to dimer B2.
These data were used to determine the transitions used in the
multiple reaction monitoring experiments to identify procyanidin
dimers in the plasma. Thus, the dimers are detected by pairing a
specific precursor ion (m/z: 577.3) with a structurally distinct
product ion (either m/z 407.0, 289.0, or 125.0). The LC-MS/MS
results of the purified procyanidin dimer standard are shown in
Figure 3A, and the procyanidin dimers in the plasma extract of
one subject 2 h after consumption of the cocoa beverage are rep-
resented in Figure 3B.
Plasma monomer and dimer B2 concentrations
An unknown peak with a retention time of 14.7 min was
detected in the plasma extract 0.5, 2, and 6 h after consumption of
0.375 g cocoa/kg body wt. We later confirmed by coelution with
the purified dimer standards that this unknown peak in the plasma
extract corresponded with the first peak observed in the purified
dimer standard (retention time: 14.7 min). As stated above, we
characterized the dimer peak at this retention time as dimer B2.
Representative chromatographs at 700 mV from one sub-
ject are shown in Figure 4. These chromatographs show the
presence of the dimer B2 peak in the plasma at 0.5, 2, and
6 h. Dimer B5 (retention time: 20.3 min) was not detected in
the plasma by coulometric detection at any time point in any
of the subjects. The plasma concentrations of the dimer B2
were significantly (P < 0.05) elevated at 0.5, 2, and 6 h rel-
ative to baseline (16 ± 5, 41 ± 4, and 15 ± 2 nmol/L, respec-
tively) (Figure 5).
Thirty minutes after the subjects consumed 0.375 g cocoa/kg
body wt, plasma epicatechin and catechin concentrations
increased significantly (P < 0.05) above baseline (0.08 ± 0.46
compared with 2.61 ± 0.46 mol/L and 0.00 compared with
0.13 ± 0.03 mo/L, respectively). Plasma concentrations of
epicatechin and catechin continued to increase, with values
at 2 h being 5.92 ± 0.60 and 0.16 ± 0.03 mol/L, respec-
tively. Plasma concentrations of epicatechin and catechin
by guest on June 6, 2013ajcn.nutrition.orgDownloaded from
802 HOLT ET AL
FIGURE 4. The detection of dimer B2 in one subject 0, 0.5, 2, and 6 h after consumption of 0.375 g cocoa/kg body wt. At baseline (0 h), dimer B2
was undetectable, increasing in concentration to 17.5 nmol/L at 0.5 h, to 51.5 nmol/L at 2 h, and to 21.5 nmol/L 6 h after cocoa consumption. The limit
of detection for dimer B2 was 10 nmol/L. The treatment of samples and HPLC conditions are as described in the text.
FIGURE 5. Mean (± SEM) plasma dimer B2, catechin, and epicate-
chin concentrations 0, 0.5, 2, and 6 h after consumption of 0.375 g cocoa/kg
body wt (n = 5).
*
Significantly different from baseline (0 h), P < 0.05.
were lower 6 h after cocoa consumption: 1.05 ± 0.01 and
0.02 ± 0.002 mol/L, respectively (Figure 5).
DISCUSSION
The flavanols and the related oligomers of this basic subunit,
known as the procyanidins, can be found in a variety of foods,
including apples, wine, tea, peanuts, almonds, and cocoa (3, 10).
Although many papers have determined the time course of
monomer absorption into plasma (19, 22–26), there is limited
information concerning the metabolism of the procyanidins. Some
studies have used radiolabeled techniques to indicate that extracts
containing procyanidins are bioavailable (27, 28). However, the
question remains whether the procyanidins are depolymerized or
remain intact before absorption. Deprez et al (29) reported that
procyanidins, with an average polymerization of 6, could be
degraded after 48 h incubation with human colonic microflora into
low-molecular-weight aromatic acids. As for the smaller
oligomers, it was reported that radiolabeled monomers, dimers,
and trimers can be transported across an in vitro cell layer of
Caco-2 cells, whereas the larger oligomers adhere to the cell sur-
face (30). Complementing the above, using procyanidins isolated
from cocoa, Spencer et al (31) perfused a 50-mol/L dimer solu-
tion for 90 min through the small intestine of rats. Small amounts
(< 1%) of the procyanidin dimers B2 and B5 were shown to pass
through the rat enterocytes, in vitro, with 95.8% of the total pass-
ing flavanols being unconjugated epicatechin. These data support
the concept that the dimers can be absorbed in vivo, albeit to a
lesser extent than the monomer subunits of the depolymerized
dimers. In the current study, we identified and quantified dimer
B2 using coulometric multiple-array detection in the plasma after
the subjects consumed a flavanol-rich cocoa beverage. We con-
firmed the presence of the procyanidin dimers in extracted plasma
samples by using LC-MS/MS. The use of LC-MS/MS enabled us
to confirm that unpolymerized dimers were present in the plasma
samples by locking onto ions that had an m/z of 577 and were
associated with structure-dependent product (dimer) ion fragments
that are unique to this procyanidin oligomer.
Consistent with the in vitro findings of Spencer et al (31), we
detected relatively modest concentrations of dimer B2 in the
by guest on June 6, 2013ajcn.nutrition.orgDownloaded from
EPICATECHIN, CATECHIN, AND DIMERS IN PLASMA 803
plasma relative to the monomers. In the current study, a mean
plasma dimer B2 concentration of 41 nmol/L was observed 2 h
after the consumption of 256 mg dimers in the cocoa; the dimer
represented < 1% of the circulating nonmethylated flavanols com-
pared with an average plasma epicatechin concentration of
5.92 mol/L at the same time point. Interestingly, although the
measured ratio of epicatechin to catechin was 1:1 in the cocoa
preparation, epicatechin was the predominant plasma flavanol,
with plasma catechin concentrations being only 3% of the plasma
epicatechin concentration. A similar observation was previously
made by Rein et al (18). Complementing these findings, epicate-
chin was reported to be the primary bioavailable form of the pro-
cyanidin dimers B2 and B5 in an isolated intestine model (31).
The combination of these results suggests that dimers and other
procyanidin oligomers may be degraded in the gut into epicate-
chin monomers that are then adsorbed. On the basis of this con-
cept, only a limited amount of oligomer is absorbed. These obser-
vations provide an explanation for the high ratio of epicatechin to
catechin observed in the current study. Further research on this issue
is warranted. It will be interesting to characterize the effects of cat-
echin-containing dimers such as B1 [epicatechin-(4-8)-catechin]
and B3 [catechin-(4-8)-catechin], which are predominant in red
wine and grape juice, on ratios of plasma epicatechin to catechin.
Information on the above will provide insight as to whether the
observed high ratio of epicatechin to catechin in the current study
is due to the absorption of the monomers after the degradation of
the oligomers in the gut or whether the ratio represents a prefer-
ential absorption of epicatechin.
With respect to the physiologic relevance of the in vivo plasma
concentrations observed in this study, in vitro studies have
reported an IC
50
(concentration that yields 50% inhibition,
expressed as mol monomer) of a cocoa extract of dimer B2 as
5 mol/L for an azo compound–dependent liposome oxidation
and 2 mol/L for an iron- and ascorbate-dependent liposome oxi-
dation (32). A dimer extract increased the lag time of conjugated
diene formation by 47% from control and at a concentration of
290 nmol/L (32). These data support the concept that low nanomo-
lar concentrations of dimers may have significant in vivo effects.
We previously reported increases in plasma antioxidant capac-
ity and reductions in lipid oxidation products with concurrent
increases of plasma epicatechin concentrations (33). Dose-
response increases in plasma epicatechin after the feeding of var-
ious amounts of cocoa flavonoids have also been reported by
Richelle et al (19). There was considerable disparity between the
reported plasma epicatechin concentrations in the current study
and in that by Richelle et al. In a recent report by Baba et al (26),
the consumption of cocoa flavonoids was associated with a rise in
plasma epicatechin concentrations to concentrations similar to
those in the current study.
In the current study, we pretreated the plasma samples with a
solution of -glucuronidase (EC 3.2.1.31) and arylsulfatase
(EC 3.1.6.1). With this approach we measured nonmethylated
(free, glucuronide, sulfide, and glucuronide-sulfide) plasma con-
jugates of epicatechin, catechin, and dimer B2; the individual con-
jugates were not analyzed. Consistent with our findings, Baba et al
(26) reported nonmethylated plasma epicatechin concentrations
of 3.46 mol/L in healthy subjects 2 h after they consumed a
cocoa drink that provided 220 mg epicatechin. Baba et al (26)
reported a concentration of 1.46 mol methylated epicatechin/L in
the plasma at the 2-h time point; free epicatechin represented 4.5%
of the total of methylated and nonmethylated epicatechin.
Only a limited amount of studies have examined the biological
effects of the conjugates. Harada et al (34) reported that glucuronide
conjugates of epicatechin and catechin have similar superoxide anion
scavenging activities compared with the aglycones; however,
reduced activities were measured with the methylglucuronide con-
jugates of both catechin and epicatechin. Similarly, Da Silva et al
(35) reported that rat plasma containing predominantly nonmethy-
lated conjugates was more effective in inhibiting radical-generated
hydroperoxides than was plasma containing primarily methylated
conjugates. Finally, Manach et al (36) observed that quercetin glu-
curonides and sulfides increased the inhibition of copper-induced
LDL oxidation, however, to a lesser extent than that of aglycone. The
abovementioned studies suggest that the nonmethylated conjugates
possess, although possibly to a lesser extent, the biological effects
that are observed in vitro with free epicatechin, catechin, and dimer.
In conclusion, although several investigators have observed
positive vascular effects in healthy adults given flavonoid-rich
foods such as whole grape juice (37–39) and cocoa (33, 40–42);
the components in these foods that are responsible for these effects
have not been definitively identified. The evidence presented here
establishes that the procyanidin oligomer dimer B2, as well as the
flavanol monomers epicatechin and catechin, can be absorbed into
the circulation. Additional work is needed to determine whether
even larger procyanidins can be absorbed. Future investigation is
also needed to determine whether the reported in vitro effects of
these procyanidin oligomers occur in vivo.
We thank Jodi L Ensunsa, Heather R Schrader, Malina Karim, and Tim J Orozco
for their assistance with this investigation
REFERENCES
1. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ,
Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coro-
nary heart disease among men. JAMA 1996;275:447–51.
2. Krauss RM, Eckel RH, Howard B, et al. AHA dietary guidelines revi-
sion 2000: a statement for healthcare professionals from the nutrition
committee of the American Heart Association. Circulation 2000;102:
2284–99.
3. Adamson GE, Lazarus SA, Mitchell AE, et al. HPLC method for the
quantification of procyanidins in cocoa and chocolate samples and
correlation to total antioxidant capacity. J Agric Food Chem 1999;47:
4184–8.
4. Prior R, Cao G. Analysis of botanicals and dietary supplements for
antioxidant capacity: a review. J AOAC Int 2000;83:950–6.
5. Richelle M, Tavazzi I, Offord E. Comparison of the antioxidant activ-
ity of commonly consumed polyphenolic beverages (coffee, cocoa,
and tea) prepared per cup serving. J Agric Food Chem 2001;49:
3438–42.
6. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D.
Dietary antioxidant flavonoids and risk of coronary heart disease: the
Zutphen Elderly Study. Lancet 1993;342:1007–11.
7. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and
long-term risk of coronary heart disease and cancer in the Seven
Countries Study. Arch Intern Med 1995;155:381–6.
8. Knekt P, Jarvinene R, Reunanen A, Maatela J. Flavonoid intake and
coronary mortality in Finland: a cohort study. BMJ 1996;312:478–81.
9. Dillinger TL, Barriga P, Escarcega S, Jimenez M, Lowe DS, Grivetti LE.
Food of the gods: cure for humanity? A cultural history of the medicinal
and ritual use of chocolate. J Nutr 2000;130:2057S–72S.
10. Lazarus SA, Adamson GE, Hammerstone JF, Schmitz HH. High-
performance liquid chromatography/mass spectrometry analysis of
proanthocyanidins in foods and beverages. J Agric Food Chem 1999;
47:3693–701.
by guest on June 6, 2013ajcn.nutrition.orgDownloaded from
804 HOLT ET AL
11. Pearson DA, Schmitz HH, Lazarus SA, Keen CL. Inhibition of in
vitro low-density lipoprotein oxidation by oligomeric procyanidins
present in chocolate and cocoas. In: Packer L, ed. Methods in enzy-
mology. New York: Academic Press, 2001:350–60.
12. Arteel GE, Schroeder P, Sies H. Reactions of peroxynitrite with cocoa
procyanidin oligomers. J Nutr 2000;130:2100S–4S.
13. Arteel GE, Sies H. Protection against peroxynitrite by cocoa
polyphenol oligomers. FEBS Lett 1999;462:167–70.
14. Karim M, McCormick K, Kappagoda CT. Effects of cocoa procyani-
dins on endothelium-dependent relaxation. J Nutr 2000;130:2105S–8S.
15. Mao T, Van De Water J, Keen CL, Schmitz H, Gershwin M. Cocoa
procyanidins and human cytokine transcription and secretion. J Nutr
2000;130:2093S–9S.
16. Mao T, Powell J, Van de Water J, Keen CL, Schmitz H, Gershwin M.
The influence of cocoa procyanidins on the transcription of inter-
leukin-2 in peripheral blood mononuclear cells. Int J Immunother
1999;15:23–9.
17. Spencer JP, Chaudry F, Pannala AS, Srai SK, Debnam E, Rice-Evans C.
Decomposition of cocoa procyanidins in the gastric milieu. Biochem
Biophys Res Commun 2000;272:236–41.
18. Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, Fraga CG.
Epicatechin in human plasma: In vivo determination and effect of
chocolate consumption on plasma oxidation status. J Nutr 2000;130:
2109S–14S.
19. Richelle M, Tavazzi I, Enslen M, Offord E. Plasma kinetics in man of
epicatechin from black chocolate. Eur J Clin Nutr 1999;53:22–6.
20. Hammerstone JF, Lazarus SA, Mitchell AE, Rucker R, Schmitz HH.
Identification of procyanidins in cocoa (Theobroma cacao) and
chocolate using high-performance liquid chromatography/mass spec-
trometry. J Agric Food Chem 1999;47:490–6.
21. Zhu QY, Holt RR, Lazarus SA, et al. Stability of the flavan-3-ols epi-
catechin and catechin and related dimeric procyanidins derived from
cocoa. J Agric Food Chem 2002;50:1700–5.
22. Bell JR, Donovan JL, Wong R, et al. (+)-Catechin in human plasma
after ingestion of a single serving of reconstituted red wine. Am J
Clin Nutr 2000;71:103–8.
23. Lee M-J, Wang Z-Y, Li H, et al. Analysis of plasma and urinary tea
polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev
1995;4:393–9.
24. Piskula MK, Terao J. Accumulation of ()-epicatechin metabolites
in rat plasma after oral administration and distribution of conjugation
enzymes in rat tissues. J Nutr 1998;128:1172–8.
25. Chen L, Lee M-J, Yang CS. Absorption, distribution, and elimination
of tea polyphenols in rats. Drug Metab Dispos 1997;25:1045–50.
26. Baba S, Osakabe N, Yasuda A, et al. Bioavailability of ()-epicatechin
upon intake of chocolate and cocoa in human volunteers. Free Radic
Res 2000;33:635–41.
27. Laparra J, Michaud J, Masquelier J. Etude pharmacocinetique des
oligomeres flavanoliques. (Pharmacokinetic study of flavonic
oligomers.) Plant Med Phytother 1977;11:133–42 (in French).
28. Jimenez-Ramsey LM, Rogler JC, Housley TL, Butler LG, Elkin RG.
Absorption and distribution of
14
C-labeled condensed tannins and
related sorghum phenolics in chickens. J Agric Food Chem 1994;
42:963–7.
29. Deprez S, Brezillon C, Rabot S, et al. Polymeric proanthocyanidins
are catabolized by human colonic microflora into low-molecular-weight
phenolic acids. J Nutr 2000;130:2733–8.
30. Santos-Buelga C, Scalbert A. Proanthocyanidins and tannin-like
compounds—nature, occurrence, dietary intake and effects on nutri-
tion and health. J Sci Food Agric 2000;80:1094–117.
31. Spencer JP, Schroeter H, Shenoy B, Srai SK, Debnam E, Rice-Evans C.
Epicatechin is the primary bioavailable form of the procyanidin dimers
B2 and B5 after transfer across the small intestine. Biochem Biophys
Res Commun 2001;285:588–93.
32. Lotito SB, Actis-Goretta L, Renart L, et al. Influence of oligomer
chain length on the antioxidant activity of procyanidins. Biochem
Biophys Res Commun 2000;276:945–51.
33. Wang JF, Schramm DD, Holt RR, et al. A dose-response effect from
chocolate consumption on plasma epicatechin and oxidative damage.
J Nutr 2000;130:2115S–9S.
34. Harada M, Kan Y, Naoki H, et al. Identification of the major
antioxidative metabolites in biological fluids of the rat with
ingested (+)-catechin and ()-epicatechin. Biosci Biotechnol
Biochem 1999;63:973–7.
35. Da Silva EL, Piskula MK, Terao J. Enhancement of antioxidative
ability of rat plasma by oral administration of ()-epicatechin. Free
Radic Biol Med 1998;24:1209–16.
36. Manach C, Morand C, Crespy V, et al. Quercetin is recovered in
human plasma as conjugated derivatives which retain antioxidant
properties. FEBS Lett 1998;426:331–6.
37. Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange
juice or grapefruit juice, inhibits human platelet aggregation. J Nutr
2000;130:53–6.
38. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD. Purple
grape juice improves endothelial function and reduces the suscepti-
bility of LDL cholesterol to oxidation in patients with coronary artery
disease. Circulation 1999;100:1050–5.
39. Freedman JE, Parker CI, Li L, et al. Select flavonoids and whole juice
from purple grapes inhibit platelet function and enhance nitric oxide
release. Circulation 2001;103:2792–8.
40. Osakabe N, Baba S, Yasuda A, et al. Daily cocoa intake reduces
the susceptibility of low-density lipoprotein to oxidation as
demonstrated in healthy human volunteers. Free Radic Res 2001;
34:93–9.
41. Rein D, Paglieroni, Teresa G, et al. Cocoa inhibits platelet activation
and function. Am J Clin Nutr 2000;72:30–5.
42. Schramm DD, Wang JF, Holt RR, et al. Chocolate procyanidins
decrease the leukotriene-prostacyclin ratio in humans and human aor-
tic endothelial cells. Am J Clin Nutr 2001;73:36–40.
by guest on June 6, 2013ajcn.nutrition.orgDownloaded from
... In our study, the detection of microbial-derived metabolites, such as phenylvaleric and phenylpropanoic acids, is limited due to the single-dose administration and the short sampling time (2 h post-administration). Their microbial-dependent metabolism delays their plasma appearance, becoming detectable only after repeated dosing and extended sampling (Mena et al. 2019). Although higher molecular weight procyanidins, such as B-oligomers (dimers and trimers), are generally considered poorly absorbed (Santos-Buelga and Scalbert 2000) in line with our results, some studies have detected the presence of B2 in human plasma after flavanol-rich ingestion (Holt et al. 2002). This suggests that, at sufficiently high doses, small amounts of these compounds may cross the intestinal barrier. ...
Article
The consumption of grape seed procyanidin extract (GSPE) may improve metabolic alterations and molecular clock desynchrony in white adipose tissue (WAT), depending on administration timing and metabolic status. To test this hypothesis, inguinal WAT explants from lean and obese PERIOD2::LUCIFERASE (PER2::LUC) circadian reporter mice were treated at the peak or trough of the PER2 luminescence rhythm with metabolites present in the serum of GSPE-administered rats (GSPM). PER2::LUC rhythms of explants from obese animals presented a lower amplitude, longer period and a phase delay. GSPM treatment increased luminescence amplitude and period compared to untreated explants, but only when it was given at the trough of PER2::LUC luminescence. GSPM upregulated lipogenesis and lipolysis genes in explants from lean mice, mostly when given at the luminescence peak. This study provides a valuable platform for testing the effects of natural products ex vivo and warrants further investigation into the chrono-utilisation of plant bioactive compounds.
... The baPWV, systolic blood pressure (SB), diastolic blood pressure (DB), and HR were recorded at pre-intervention and 15, 30, 45, and 60-min intervals post-intervention. The first baPWV measurement was conducted 1 h after blueberry juice consumption, which coincides with the reported peak in plasma polyphenol metabolite concentration (1-2 h postingestion) 45 . Blood samples were collected from all participants both before and 30 min after the intervention. ...
Article
Full-text available
Arterial stiffness, a cardiovascular disease (CVD) predictor starting from youth, is under-researched in young adults. Low-intensity aerobic exercise (LAE) is generally more accessible than higher-intensity exercise and may be more sustainable for young individuals. Blueberries, renowned for vascular health benefits, may reduce arterial stiffness. This study examines the effects of LAE and blueberry juice on arterial stiffness in 48 young adults. Participants were randomized into LAE, low-, mid-, or high-volume blueberry juice (LB, MB, HB), LAE + LB, LAE + MB, LAE + HB, and control groups. Arterial stiffness was measured at baseline and at 15-, 30-, 45-, and 60 min post-intervention. Blood samples were collected pre-intervention and 30-min post-intervention for metabolomic analysis. Repeated ANOVA revealed LAE + MB significantly reduced arterial stiffness. Metabolomic analysis revealed changes in linoleic acid, sphingolipid, phenylalanine, nicotinate and nicotinamide, glycerophospholipid, and lysine degradation metabolic pathways. These findings suggest a feasible exercise-diet strategy for CVD prevention in young adults and provide metabolic insights into the mechanisms.
... Monomeric and oligomeric PACs are more bioavailable than those characterized by a higher degree of polymerization. This property leads to increased bioactivity, as low molecular weight PACs can reach the target tissues more effectively and exert more pronounced biological effects [22][23][24]. Based on this consideration, in our previous study, we demonstrated that a food-grade treatment enables the depolymerization of PAC polymers from grape seed extract (GSE) (Vitis vinifera L.) into lower molecular weight oligomers and monomers by alkaline treatment [25]. ...
Article
Full-text available
Background/objectives: Benign prostatic hyperplasia (BPH) is one of the most common chronic diseases affecting the urinary tract that occurs mainly in men over 40 years of age. Among the natural therapies, proanthocyanidins (PACs), which can treat a wide range of immune-mediated inflammatory diseases (IMIDs), have been shown to play an important role in the treatment of pathologies concerning prostate health. In this regard, the present study aimed to evaluate the different bioactivities of a grape seed extract (GSE), rich in polymeric PACs, and its version processed under alkaline conditions (ATGSE), characterized by a higher content of oligomeric PACs, in an animal model of BPH induced by subcutaneous injection of testosterone (1 mg/mouse). Methods: These latter were divided into a control group (vehicle, olive oil), a BPH group (testosterone 1 mg/mouse), and four treatment groups treated with GSE (500 mg/kg) and ATGSE (125, 250, 500 mg/kg) by oral gavage. At the experimental endpoint (4 weeks), hematological and biochemical analyses of blood and tissues were performed. Results: Data showed that oral administration of ATGSE (250 mg/kg) was significantly more effective than GSE in reducing prostate (p ≤ 0.0001) and seminal vesicle (p ≤ 0.0001) weight. Moreover, ATGSE exhibited enhanced effectiveness in significantly reducing PSA levels (p ≤ 0.0001 vs. GSE) and the expression of key pro-inflammatory cyto-chemokines in prostate and seminal vesicles homogenates. Conclusions: These findings pave the way for the clinical application of ATGSE as a nutraceutical and/or functional food.
... They are often subject to pH-dependent transformations into various phenolic metabolites, most of which have been credited for the in vivo therapeutic benefits of PAC (Ludwig et al., 2015). Although only small amounts of dimeric procyanidins, for instance, are reported to be absorbed intact (Holt et al., 2002;Sano et al., 2003), most are degraded in the colon into benzoic, hippuric, phenylacetic, phenylpropionic, and phenylvaleric acids, which may contribute to the therapeutic role of these polyphenols (Gonthier et al., 2003a;Gonthier et al., 2003b;Rios et al., 2003;Ou and Gu, 2014;Ludwig et al., 2015). ...
Article
Full-text available
Some tannin-rich plants such as Combretum mucronatum and Phyllanthus urinaria are widely used in Africa for the control of parasitic nematodes in both humans and livestock. Tannins have been recognized as an alternative source of anthelmintic therapies, and hence, recent studies have focused on both the hydrolyzable and condensed tannins. These groups of compounds, however, have poor oral bioavailability and are metabolized by gut microbiota into lower molecular weight compounds. The role of these metabolites in the anthelmintic activities of tannins has not been explored yet. This study investigated the effects of fecal metabolism on the anthelmintic potential of procyanidin C1 (PC1) and geraniin and the tannin-enriched extracts of C. mucronatum (CML) and P. urinaria (PUH), which contain these compounds, respectively. Metabolites were formed by anaerobic fermentation of the test compounds and extracts in a fresh human fecal suspension for 0 h, 4 h, and 24 h. Lyophilized samples were tested in vitro against hookworm larvae and whipworm (Trichuris trichiura) larvae obtained from naturally infected human populations in Pru West District, Bono East Region, Ghana, and against the wildtype strain of Caenorhabditis elegans (L4). Both extracts and compounds in the undegraded state exhibited concentration-dependent inhibition of the three nematodes. Their activity, however, significantly decreased upon fecal metabolism. Without fermentation, the proanthocyanidin-rich CML extract was lethal against hookworm L3 (LC50 = 343.5 μg/mL, 95% confidence interval (CI) = 267.5–445.4), T. trichiura L1 (LC50 = 230.1 μg/mL, CI = 198.9–271.2), and C. elegans (LC50 = 1468.1 μg/mL, CI = 990.3–1946.5). PUH, from which the ellagitannin geraniin was isolated, exhibited anthelmintic effects in the unfermented form with LC50 of 300.8 μg/mL (CI = 245.1–374.8) against hookworm L3 and LC50 of 331.6 μg/mL (CI = 290.3–382.5) against T. trichiura L1, but it showed no significant activity against C. elegans L4 larvae at the tested concentrations. Similarly, both compounds, procyanidin C1 and geraniin, lost their activity when metabolized in fecal matter. The activity of geraniin at a concentration of 170 μg/mL against C. elegans significantly declined from 30.4% ± 1.8% to 14.5% ± 1.5% when metabolized for 4 h, whereas that of PC1 decreased from 32.4% ± 2.3% to 8.9% ± 0.9% with similar treatment. There was no significant difference between the anthelmintic actions of metabolites from the structurally different tannin groups. The outcome of this study revealed that the intact bulky structure of tannins (hydrolyzable or condensed) may be required for their anthelmintic action. The fermented products from the gut may not directly contribute toward the inhibition of the larvae of soil-transmitted helminths.
... This procedure was previously found to be reliable in participants of both sexes (15). The time interval − 2 h after chocolate ingestion, was used in the present study in view of the fact that the cocoa flavanol epicatechin reaches its maximum plasma concentration 2 h after the consumption of a flavanol-rich food (26,27). ...
Article
Objective: Chocolate is a popular food that may affect the activity of the autonomic nervous system (ANS). The aim of this study was to determine the effect of a single dose of dark or milk chocolate on ANS cardiac control during rest and mental stress induced by the Stroop test (ST). Methods: Healthy participants, divided into DARK or MILK chocolate groups, ingested corresponding type of chocolate (1 g/kg body weight). They underwent measurement of ANS during relaxation and ST before and 2 h after chocolate consumption. ANS control was assessed by determination of heart rate (HR) and heart rate variability using parameters related to complex autonomic modulation (TP, SDNN) or primary vagal modulation (HFnu, RMSSD). Results: HR was always increased during ST in both groups. Relaxation HR values after chocolate ingestion were higher only in the DARK chocolate group. During ST, values of TP, SDNN and HFnu decreased before and after chocolate ingestion in the DARK group, but only before chocolate ingestion in the MILK group. RMSSD values decreased during ST before and after chocolate ingestion in both groups. Relaxation TP, RMSSD and HFnu values after chocolate ingestion were lower in the DARK but not in the MILK group. Conclusion: The results suggest that even a single dose of milk chocolate attenuates changes in ANS cardiac control induced by mental stress, whereas a single dose of dark chocolate has an activating effect on the heart via modification of ANS cardiac control at rest. Different levels of sugars and cocoa biologically active compounds in the two types of chocolate could explain the observed effects.
Article
Background Compared to many other foods, cocoa and chocolate stand out for their high concentrations of polyphenols, particularly catechins, anthocyanidins, and procyanidins. These compounds possess antioxidant, anti-inflammatory, and vasodilatory properties that can confer multiple health benefits. This present study has been undertaken to assess the effects of polyphenol- rich chocolate consumption on various aspects of human health, including mood, cognition, cardiovascular health, insulin sensitivity, immune function, gut microbiota, and cancer risk. The high polyphenolic content in dark chocolates improves endothelial function, inhibits platelet aggregation, lowers blood pressure, enhances insulin sensitivity, etc. Cocoa polyphenols have been found to augment cognitive performance due to their ability to modulate gut microbiota. Potential antidepressant and anticarcinogenic activities were also reported. Objective The present study aimed to identify the impact of polyphenol-rich chocolate on human health. Methods Electronic searches were carried out using the databases viz. Google, Google Scholar, and PubMed for the study. The search was restricted for a period of 48 years, ranging from 1980 - 2022, to make it more systematic and concise. The obtained research and review articles were thoroughly studied and analyzed to present a comprehensive review. Findings The findings of the present study mainly focus on the impact of polyphenols on human health, especially cognitive status. Evidence indicates that polyphenol-rich dark chocolate might offer numerous advantages for cardiovascular and metabolic health, but its effects on cognition, mental health, gut microbiota, and cancer risk need to be studied further. More research, including animal experiments and human trials, is needed to understand the health impact and optimal dosages of dark chocolate. Understanding chocolate’s therapeutic benefits can open new avenues for human well-being. Conclusion The complex relationship between chocolate and emotion via the gut-brain axis has been discussed. From the momentary sensory pleasures to the intriguing interplay between cravings and comfort-seeking behaviors, chocolate has a unique place in the realm of emotional indulgence.
Article
In this study, we describe the effect of cocoa polyphenol extract (CPE, from flavanols‐rich cocoa) on myogenic differentiation in murine myoblasts (C2C12 cells) exposed to H 2 O 2 . The myogenic program was monitored using morphological, ultrastructural, and molecular approaches. Treatment with 100 μM of H 2 O 2 for 1 h decreased cell viability. C2C12 (D1) exposed to H 2 O 2 shows more apoptotic and necrotic cells, and mitochondria appear emptied, with cristae heavily damaged. To evaluate the effect of CPE on myoblast viability and myotube formation, 10 μg/mL of CPE were added 24 h prior to H 2 O 2 treatment and cells were supplemented with fresh CPE every 24 h during differentiation. Supplementation with CPE protected C2C12 myoblasts from H 2 O 2 ‐induced oxidative damage both at early (D1) and late (D6) phases of differentiation, preventing cell death and mitochondrial damage. The number of mitochondria (per area of cell surface) increased 2‐fold in both control and in CPE‐supplemented and mitochondria in myotubes D6 showed a greater extension of mitochondrial cristae than mitochondria in D1. At D1 and D6 the monolayers showed surface and inner cell features relatively comparable to the untreated control suggesting that CPE supplementation significantly mitigated the effect of H 2 O 2 . Preliminary data obtained by the myogenic index (Giemsa staining) suggested that CPE‐supplemented cells were partially protected from H 2 O 2 ‐induced myogenesis inhibition. The CPE supplementation seems to preserve the mitochondrial integrity and the myogenic differentiation ability of oxidatively injured C2C12 ensuing further nutraceutical perspectives.
Article
Full-text available
Monomeric and oligomeric procyanidins present in cocoa liquors and chocolates were separated and quantified in four different laboratories using a normal-phase high-performance liquid chromatography (HPLC) method with fluorescence detection. Procyanidin standards through decamers were obtained by extraction from cocoa beans, enrichment by Sephadex LH-20 gel permeation chromatography, and final purification by preparative normal-phase HPLC. The purity of each oligomeric fraction was assessed using HPLC coupled to mass spectrometry. A composite standard was then prepared, and calibration curves were generated for each oligomeric class using a quadratic fit of area sum versus concentration. Results obtained by each of the laboratories were in close agreement, which suggests this method is reliable and reproducible for quantification of procyanidins. Furthermore, the procyanidin content of the samples was correlated to the antioxidant capacity measured using the ORAC assay as an indicator for potential biological activity. Keywords: HPLC; procyanidins; cocoa; chocolate; quantification; antioxidant
Article
Proanthocyanidins (syn condensed tannins) are complex flavonoid polymers naturally present in cereals, legume seeds and particularly abundant in some fruits and fruit juices. They share some common structural features—phenolic nature and high molecular weight—with phenolic polymers found in black tea and red wine (called here tannin‐like compounds). The polymeric nature of proanthocyanidins makes their analysis and estimation in food difficult. For this reason, little is known about their consumption, although they likely contribute a large part of the daily polyphenol intake. They also share common physicochemical properties: they form stable complexes with metal ions and with proteins and are, like other polyphenols, good reducing agents. Many of their biological effects of nutritional interest derive from these properties. As metal ion chelators, they influence the bioavailability of several minerals. The nutritional significance of the non‐specific complexation of proteins is less clear. As reducing agents, they may participate in the prevention of cancers, both of the digestive tract and inner organs. They may also protect LDLs against oxidation and inhibit platelet aggregation and therefore prevent cardiovascular diseases. In vitro , animal and human studies on the prevention of these chronic diseases are reviewed with particular attention to wine and tea polyphenols. The lack of data on their bioavailability and the paucity of human studies are emphasised. © 2000 Society of Chemical Industry
Article
The aim of this study was to examine the effects of procyanidins derived from cocoa on vascular smooth muscle. Two hypotheses were tested: 1) extracts of cocoa, which are rich in procyanidins, cause endothelium-dependent relaxation (EDR), and 2) extracts of cocoa activate endothelial nitric oxide synthase (NOS), The experiments were carried out on aortic rings obtained from New Zealand White rabbits. The polymeric procyanidins (tetramer through decamer of catechin) caused an EDR. In addition, the Ca2+-dependent NOS activity, measured by the L-arginine to L-citrulline conversion assay, was significantly increased in aortic endothelial cells exposed to polymeric procyanidins, whereas monomeric compounds had no such effect. These findings demonstrate that polymeric procyanidins cause an EDR that is mediated by activation of NOS.
Article
We have previously shown that cocoa polyphenols (procyanidins) inhibit induced nuclear transcription of human interleukin-1β. In the present study we extend the observed immunomodulatory activity to examine the effects of cocoa procyanidins on the interleukin-2 (IL-2) gene. The transcriptional regulation of IL-2 is critically involved in the control of T-cell proliferation and normal immune response. Both resting and phytohemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC) were investigated. Neither the crude cocoa extract, a procyanidin-enriched extract nor individual oligomeric procyanidins stimulated IL-2 in resting PBMC. However both the crude and the procyanidin-enriched extracts reduced IL-2 transcription in PHA-stimulated cells by 67% and 58%, respectively. Experiments with isolated procyanidins showed that while the monomeric fraction did not alter IL-2 expression, the pentamer; hexamer and heptamer caused a 61-73% inhibition. Thus, it appears that procyanidin oligomers, present in cocoa and chocolate to a significant extent, are responsible for the inhibition of PHA-induced stimulation of IL-2 in PBMC. This provides an additional mechanism in immune regulation when considering the health-benefits of dietary polyphenols from a wide variety of foods and suggests the potential clinical utility of cocoa or its derivatives on disorders of activated immune function.
Article
Objective: To determine whether flavonoid intake explains differences in mortality rates from chronic diseases between populations.Design: Cross-cultural correlation study.Setting/Participants: Sixteen cohorts of the Seven Countries Study in whom flavonoid intake at baseline around 1960 was estimated by flavonoid analysis of equivalent food composites that represented the average diet in the cohorts.Main Outcome Measures: Mortality from coronary heart disease, cancer (various sites), and all causes in the 16 cohorts after 25 years of follow-up.Results: Average intake of antioxidant flavonoids was inversely associated with mortality from coronary heart disease and explained about 25% of the variance in coronary heart disease rates in the 16 cohorts. In multivariate analysis, intake of saturated fat (73%; P=.0001), flavonoid intake (8%; P=.01), and percentage of smokers per cohort (9%; P=.03) explained together, independent of intake of alcohol and antioxidant vitamins, 90% of the variance in coronary heart disease rates. Flavonoid intake was not independently associated with mortality from other causes.Conclusions: Average flavonoid intake may partly contribute to differences in coronary heart disease mortality across populations, but it does not seem to be an important determinant of cancer mortality.(Arch Intern Med. 1995;155:381-386)
Article
Objective. —To examine prospectively the relationship between dietary fiber and risk of coronary heart disease.Design. —Cohort study.Setting. —In 1986, a total of 43 757 US male health professionals 40 to 75 years of age and free from diagnosed cardiovascular disease and diabetes completed a detailed 131 -item dietary questionnaire used to measure usual intake of total dietary fiber and specific food sources of fiber.Main Outcome Measure. —Fatal and nonfatal myocardial infarction (Ml).Results. —During 6 years of follow-up, we documented 734 cases of Ml (229 were fatal coronary heart disease). The age-adjusted relative risk (RR) for total Ml was 0.59 (95% confidence interval [CI], 0.46 to 0.76) among men in the highest quintile of total dietary fiber intake (median, 28.9 g/d) compared with men in the lowest quartile (median, 12.4 g/d). The inverse association was strongest for fatal coronary disease (RR, 0.45; 95% CI, 0.28 to 0.72). After controlling for smoking, physical activity and other known nondietary cardiovascular risk factors, dietary saturated fat, vitamin E, total energy intake, and alcohol intake, the RRs were only modestly attenuated. A 10-g increase in total dietary fiber corresponded to an RR for total Ml of 0.81 (95% CI, 0.70 to 0.93). Within the three main food contributors to total fiber intake (vegetable, fruit, and cereal), cereal fiber was most strongly associated with a reduced risk of total Ml (RR, 071; 95% CI, 0.55 to 0.91 for each 10-g increase in cereal fiber per day).Conclusions. —Our results suggest an inverse association between fiber intake and Ml. These results support current national dietary guidelines to increase dietary fiber intake and suggest that fiber, independent of fat intake, is an important dietary component for the prevention of coronary disease.(JAMA. 1996;275:447-451)
Article
To determine whether flavonoid intake explains differences in mortality rates from chronic diseases between populations. Cross-cultural correlation study. Sixteen cohorts of the Seven Countries Study in whom flavonoid intake at baseline around 1960 was estimated by flavonoid analysis of equivalent food composites that represented the average diet in the cohorts. Mortality from coronary heart disease, cancer (various sites), and all causes in the 16 cohorts after 25 years of follow-up. Average intake of antioxidant flavonoids was inversely associated with mortality from coronary heart disease and explained about 25% of the variance in coronary heart disease rates in the 16 cohorts. In multivariate analysis, intake of saturated fat (73%; P = 0.0001), flavonoid intake (8%, P = .01), and percentage of smokers per cohort (9%; P = .03) explained together, independent of intake of alcohol and antioxidant vitamins, 90% of the variance in coronary heart disease rates. Flavonoid intake was not independently associated with mortality from other causes. Average flavonoid intake may partly contribute to differences in coronary heart disease mortality across populations, but it does not seem to be an important determinant of cancer mortality.